nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—kidney cancer—muscle cancer	0.691	1	CtDrD
Capecitabine—TYMS—Methotrexate—muscle cancer	0.132	1	CbGbCtD
Capecitabine—CES1—larynx—muscle cancer	0.00696	0.21	CbGeAlD
Capecitabine—DPYD—cardiac atrium—muscle cancer	0.00208	0.0629	CbGeAlD
Capecitabine—DPYD—bone marrow—muscle cancer	0.00176	0.0531	CbGeAlD
Capecitabine—CDA—tendon—muscle cancer	0.00175	0.0528	CbGeAlD
Capecitabine—CDA—bone marrow—muscle cancer	0.00169	0.0511	CbGeAlD
Capecitabine—CDA—vagina—muscle cancer	0.00162	0.049	CbGeAlD
Capecitabine—DPYD—testis—muscle cancer	0.0015	0.0454	CbGeAlD
Capecitabine—CDA—testis—muscle cancer	0.00145	0.0437	CbGeAlD
Capecitabine—TYMP—smooth muscle tissue—muscle cancer	0.0014	0.0423	CbGeAlD
Capecitabine—TYMP—cardiac atrium—muscle cancer	0.00121	0.0365	CbGeAlD
Capecitabine—TYMS—smooth muscle tissue—muscle cancer	0.0012	0.0363	CbGeAlD
Capecitabine—TYMP—tendon—muscle cancer	0.00105	0.0318	CbGeAlD
Capecitabine—TYMS—Vinorelbine—Vincristine—muscle cancer	0.00104	0.372	CbGdCrCtD
Capecitabine—TYMS—Podofilox—Etoposide—muscle cancer	0.00104	0.372	CbGdCrCtD
Capecitabine—TYMP—bone marrow—muscle cancer	0.00102	0.0308	CbGeAlD
Capecitabine—TYMP—vagina—muscle cancer	0.000977	0.0295	CbGeAlD
Capecitabine—TYMS—tendon—muscle cancer	0.000903	0.0273	CbGeAlD
Capecitabine—TYMP—head—muscle cancer	0.000902	0.0272	CbGeAlD
Capecitabine—TYMS—bone marrow—muscle cancer	0.000875	0.0264	CbGeAlD
Capecitabine—TYMP—testis—muscle cancer	0.000872	0.0263	CbGeAlD
Capecitabine—TYMS—vagina—muscle cancer	0.000838	0.0253	CbGeAlD
Capecitabine—CES1—head—muscle cancer	0.000779	0.0235	CbGeAlD
Capecitabine—TYMS—head—muscle cancer	0.000774	0.0234	CbGeAlD
Capecitabine—CES1—testis—muscle cancer	0.000752	0.0227	CbGeAlD
Capecitabine—TYMS—testis—muscle cancer	0.000748	0.0226	CbGeAlD
Capecitabine—TYMS—Vinblastine—Vincristine—muscle cancer	0.000716	0.256	CbGdCrCtD
Capecitabine—Blood creatinine increased—Doxorubicin—muscle cancer	9.75e-05	0.00069	CcSEcCtD
Capecitabine—Dysuria—Methotrexate—muscle cancer	9.72e-05	0.000688	CcSEcCtD
Capecitabine—Neutropenia—Methotrexate—muscle cancer	9.72e-05	0.000688	CcSEcCtD
Capecitabine—Dehydration—Doxorubicin—muscle cancer	9.68e-05	0.000685	CcSEcCtD
Capecitabine—Thrombocytopenia—Etoposide—muscle cancer	9.66e-05	0.000684	CcSEcCtD
Capecitabine—Upper respiratory tract infection—Methotrexate—muscle cancer	9.66e-05	0.000684	CcSEcCtD
Capecitabine—Tachycardia—Etoposide—muscle cancer	9.63e-05	0.000681	CcSEcCtD
Capecitabine—Abdominal pain—Vincristine—muscle cancer	9.63e-05	0.000681	CcSEcCtD
Capecitabine—Body temperature increased—Vincristine—muscle cancer	9.63e-05	0.000681	CcSEcCtD
Capecitabine—Liver function test abnormal—Doxorubicin—muscle cancer	9.61e-05	0.00068	CcSEcCtD
Capecitabine—Skin disorder—Etoposide—muscle cancer	9.58e-05	0.000678	CcSEcCtD
Capecitabine—Dry skin—Doxorubicin—muscle cancer	9.54e-05	0.000675	CcSEcCtD
Capecitabine—Hyperhidrosis—Etoposide—muscle cancer	9.54e-05	0.000675	CcSEcCtD
Capecitabine—Orthostatic hypotension—Doxorubicin—muscle cancer	9.51e-05	0.000673	CcSEcCtD
Capecitabine—Abdominal pain upper—Doxorubicin—muscle cancer	9.51e-05	0.000673	CcSEcCtD
Capecitabine—Photosensitivity reaction—Methotrexate—muscle cancer	9.49e-05	0.000671	CcSEcCtD
Capecitabine—Hypokalaemia—Doxorubicin—muscle cancer	9.48e-05	0.000671	CcSEcCtD
Capecitabine—Breast disorder—Doxorubicin—muscle cancer	9.41e-05	0.000666	CcSEcCtD
Capecitabine—Anorexia—Etoposide—muscle cancer	9.41e-05	0.000666	CcSEcCtD
Capecitabine—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	9.38e-05	0.000663	CcSEcCtD
Capecitabine—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	9.38e-05	0.000663	CcSEcCtD
Capecitabine—Diarrhoea—Dactinomycin—muscle cancer	9.33e-05	0.00066	CcSEcCtD
Capecitabine—Pneumonia—Methotrexate—muscle cancer	9.32e-05	0.00066	CcSEcCtD
Capecitabine—Nasopharyngitis—Doxorubicin—muscle cancer	9.31e-05	0.000659	CcSEcCtD
Capecitabine—Infestation NOS—Methotrexate—muscle cancer	9.27e-05	0.000656	CcSEcCtD
Capecitabine—Infestation—Methotrexate—muscle cancer	9.27e-05	0.000656	CcSEcCtD
Capecitabine—Depression—Methotrexate—muscle cancer	9.24e-05	0.000654	CcSEcCtD
Capecitabine—Hypotension—Etoposide—muscle cancer	9.22e-05	0.000652	CcSEcCtD
Capecitabine—Gastritis—Doxorubicin—muscle cancer	9.22e-05	0.000652	CcSEcCtD
Capecitabine—Stevens-Johnson syndrome—Methotrexate—muscle cancer	9.19e-05	0.00065	CcSEcCtD
Capecitabine—Muscular weakness—Doxorubicin—muscle cancer	9.18e-05	0.00065	CcSEcCtD
Capecitabine—Alanine aminotransferase increased—Doxorubicin—muscle cancer	9.18e-05	0.00065	CcSEcCtD
Capecitabine—Renal failure—Methotrexate—muscle cancer	9.11e-05	0.000645	CcSEcCtD
Capecitabine—Abdominal distension—Doxorubicin—muscle cancer	9.06e-05	0.000641	CcSEcCtD
Capecitabine—Stomatitis—Methotrexate—muscle cancer	9.03e-05	0.000639	CcSEcCtD
Capecitabine—Conjunctivitis—Methotrexate—muscle cancer	9.01e-05	0.000637	CcSEcCtD
Capecitabine—Asthma—Doxorubicin—muscle cancer	9e-05	0.000637	CcSEcCtD
Capecitabine—Influenza—Doxorubicin—muscle cancer	9e-05	0.000637	CcSEcCtD
Capecitabine—Dysphagia—Doxorubicin—muscle cancer	9e-05	0.000637	CcSEcCtD
Capecitabine—Hypersensitivity—Vincristine—muscle cancer	8.97e-05	0.000635	CcSEcCtD
Capecitabine—Paraesthesia—Etoposide—muscle cancer	8.86e-05	0.000627	CcSEcCtD
Capecitabine—Haematuria—Methotrexate—muscle cancer	8.84e-05	0.000625	CcSEcCtD
Capecitabine—Dyspnoea—Etoposide—muscle cancer	8.8e-05	0.000622	CcSEcCtD
Capecitabine—Angina pectoris—Doxorubicin—muscle cancer	8.77e-05	0.00062	CcSEcCtD
Capecitabine—Hepatobiliary disease—Methotrexate—muscle cancer	8.76e-05	0.00062	CcSEcCtD
Capecitabine—Epistaxis—Methotrexate—muscle cancer	8.74e-05	0.000619	CcSEcCtD
Capecitabine—Asthenia—Vincristine—muscle cancer	8.74e-05	0.000618	CcSEcCtD
Capecitabine—Vomiting—Dactinomycin—muscle cancer	8.67e-05	0.000613	CcSEcCtD
Capecitabine—Bronchitis—Doxorubicin—muscle cancer	8.66e-05	0.000612	CcSEcCtD
Capecitabine—Agranulocytosis—Methotrexate—muscle cancer	8.65e-05	0.000612	CcSEcCtD
Capecitabine—Rash—Dactinomycin—muscle cancer	8.6e-05	0.000608	CcSEcCtD
Capecitabine—Decreased appetite—Etoposide—muscle cancer	8.58e-05	0.000607	CcSEcCtD
Capecitabine—Pancytopenia—Doxorubicin—muscle cancer	8.55e-05	0.000605	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Etoposide—muscle cancer	8.52e-05	0.000603	CcSEcCtD
Capecitabine—Fatigue—Etoposide—muscle cancer	8.51e-05	0.000602	CcSEcCtD
Capecitabine—Pain—Etoposide—muscle cancer	8.44e-05	0.000597	CcSEcCtD
Capecitabine—Constipation—Etoposide—muscle cancer	8.44e-05	0.000597	CcSEcCtD
Capecitabine—Dysuria—Doxorubicin—muscle cancer	8.42e-05	0.000595	CcSEcCtD
Capecitabine—Neutropenia—Doxorubicin—muscle cancer	8.42e-05	0.000595	CcSEcCtD
Capecitabine—Upper respiratory tract infection—Doxorubicin—muscle cancer	8.36e-05	0.000592	CcSEcCtD
Capecitabine—Haemoglobin—Methotrexate—muscle cancer	8.36e-05	0.000592	CcSEcCtD
Capecitabine—Diarrhoea—Vincristine—muscle cancer	8.33e-05	0.00059	CcSEcCtD
Capecitabine—Haemorrhage—Methotrexate—muscle cancer	8.32e-05	0.000589	CcSEcCtD
Capecitabine—Hepatitis—Methotrexate—muscle cancer	8.32e-05	0.000589	CcSEcCtD
Capecitabine—Pharyngitis—Methotrexate—muscle cancer	8.26e-05	0.000584	CcSEcCtD
Capecitabine—Urinary tract disorder—Methotrexate—muscle cancer	8.22e-05	0.000581	CcSEcCtD
Capecitabine—Photosensitivity reaction—Doxorubicin—muscle cancer	8.21e-05	0.000581	CcSEcCtD
Capecitabine—Weight increased—Doxorubicin—muscle cancer	8.19e-05	0.00058	CcSEcCtD
Capecitabine—Urethral disorder—Methotrexate—muscle cancer	8.15e-05	0.000577	CcSEcCtD
Capecitabine—Weight decreased—Doxorubicin—muscle cancer	8.14e-05	0.000576	CcSEcCtD
Capecitabine—Feeling abnormal—Etoposide—muscle cancer	8.13e-05	0.000575	CcSEcCtD
Capecitabine—Hyperglycaemia—Doxorubicin—muscle cancer	8.12e-05	0.000574	CcSEcCtD
Capecitabine—Nausea—Dactinomycin—muscle cancer	8.1e-05	0.000573	CcSEcCtD
Capecitabine—Pneumonia—Doxorubicin—muscle cancer	8.07e-05	0.000571	CcSEcCtD
Capecitabine—Gastrointestinal pain—Etoposide—muscle cancer	8.07e-05	0.000571	CcSEcCtD
Capecitabine—Dizziness—Vincristine—muscle cancer	8.05e-05	0.00057	CcSEcCtD
Capecitabine—Infestation NOS—Doxorubicin—muscle cancer	8.02e-05	0.000568	CcSEcCtD
Capecitabine—Infestation—Doxorubicin—muscle cancer	8.02e-05	0.000568	CcSEcCtD
Capecitabine—Visual impairment—Methotrexate—muscle cancer	8.02e-05	0.000567	CcSEcCtD
Capecitabine—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	7.96e-05	0.000563	CcSEcCtD
Capecitabine—Renal failure—Doxorubicin—muscle cancer	7.89e-05	0.000558	CcSEcCtD
Capecitabine—Erythema multiforme—Methotrexate—muscle cancer	7.87e-05	0.000557	CcSEcCtD
Capecitabine—Neuropathy peripheral—Doxorubicin—muscle cancer	7.87e-05	0.000557	CcSEcCtD
Capecitabine—Urticaria—Etoposide—muscle cancer	7.84e-05	0.000555	CcSEcCtD
Capecitabine—Jaundice—Doxorubicin—muscle cancer	7.82e-05	0.000553	CcSEcCtD
Capecitabine—Stomatitis—Doxorubicin—muscle cancer	7.82e-05	0.000553	CcSEcCtD
Capecitabine—Abdominal pain—Etoposide—muscle cancer	7.8e-05	0.000552	CcSEcCtD
Capecitabine—Body temperature increased—Etoposide—muscle cancer	7.8e-05	0.000552	CcSEcCtD
Capecitabine—Conjunctivitis—Doxorubicin—muscle cancer	7.8e-05	0.000552	CcSEcCtD
Capecitabine—Urinary tract infection—Doxorubicin—muscle cancer	7.8e-05	0.000552	CcSEcCtD
Capecitabine—Eye disorder—Methotrexate—muscle cancer	7.77e-05	0.00055	CcSEcCtD
Capecitabine—Tinnitus—Methotrexate—muscle cancer	7.76e-05	0.000549	CcSEcCtD
Capecitabine—Vomiting—Vincristine—muscle cancer	7.74e-05	0.000548	CcSEcCtD
Capecitabine—Cardiac disorder—Methotrexate—muscle cancer	7.72e-05	0.000546	CcSEcCtD
Capecitabine—Rash—Vincristine—muscle cancer	7.68e-05	0.000543	CcSEcCtD
Capecitabine—Dermatitis—Vincristine—muscle cancer	7.67e-05	0.000543	CcSEcCtD
Capecitabine—Haematuria—Doxorubicin—muscle cancer	7.65e-05	0.000541	CcSEcCtD
Capecitabine—Headache—Vincristine—muscle cancer	7.63e-05	0.00054	CcSEcCtD
Capecitabine—Hepatobiliary disease—Doxorubicin—muscle cancer	7.59e-05	0.000537	CcSEcCtD
Capecitabine—Epistaxis—Doxorubicin—muscle cancer	7.57e-05	0.000536	CcSEcCtD
Capecitabine—Angiopathy—Methotrexate—muscle cancer	7.55e-05	0.000534	CcSEcCtD
Capecitabine—Immune system disorder—Methotrexate—muscle cancer	7.51e-05	0.000532	CcSEcCtD
Capecitabine—Mediastinal disorder—Methotrexate—muscle cancer	7.5e-05	0.000531	CcSEcCtD
Capecitabine—Agranulocytosis—Doxorubicin—muscle cancer	7.49e-05	0.00053	CcSEcCtD
Capecitabine—Chills—Methotrexate—muscle cancer	7.46e-05	0.000528	CcSEcCtD
Capecitabine—Alopecia—Methotrexate—muscle cancer	7.35e-05	0.00052	CcSEcCtD
Capecitabine—Bradycardia—Doxorubicin—muscle cancer	7.33e-05	0.000519	CcSEcCtD
Capecitabine—Mental disorder—Methotrexate—muscle cancer	7.29e-05	0.000516	CcSEcCtD
Capecitabine—Hypersensitivity—Etoposide—muscle cancer	7.27e-05	0.000514	CcSEcCtD
Capecitabine—Erythema—Methotrexate—muscle cancer	7.24e-05	0.000512	CcSEcCtD
Capecitabine—Malnutrition—Methotrexate—muscle cancer	7.24e-05	0.000512	CcSEcCtD
Capecitabine—Haemoglobin—Doxorubicin—muscle cancer	7.24e-05	0.000512	CcSEcCtD
Capecitabine—Nausea—Vincristine—muscle cancer	7.24e-05	0.000512	CcSEcCtD
Capecitabine—Rhinitis—Doxorubicin—muscle cancer	7.22e-05	0.000511	CcSEcCtD
Capecitabine—Hepatitis—Doxorubicin—muscle cancer	7.2e-05	0.00051	CcSEcCtD
Capecitabine—Haemorrhage—Doxorubicin—muscle cancer	7.2e-05	0.00051	CcSEcCtD
Capecitabine—Hypoaesthesia—Doxorubicin—muscle cancer	7.17e-05	0.000507	CcSEcCtD
Capecitabine—Pharyngitis—Doxorubicin—muscle cancer	7.15e-05	0.000506	CcSEcCtD
Capecitabine—Urinary tract disorder—Doxorubicin—muscle cancer	7.11e-05	0.000503	CcSEcCtD
Capecitabine—Oedema peripheral—Doxorubicin—muscle cancer	7.1e-05	0.000502	CcSEcCtD
Capecitabine—Dysgeusia—Methotrexate—muscle cancer	7.09e-05	0.000502	CcSEcCtD
Capecitabine—Asthenia—Etoposide—muscle cancer	7.08e-05	0.000501	CcSEcCtD
Capecitabine—Connective tissue disorder—Doxorubicin—muscle cancer	7.08e-05	0.000501	CcSEcCtD
Capecitabine—Urethral disorder—Doxorubicin—muscle cancer	7.06e-05	0.0005	CcSEcCtD
Capecitabine—Back pain—Methotrexate—muscle cancer	7e-05	0.000496	CcSEcCtD
Capecitabine—Pruritus—Etoposide—muscle cancer	6.98e-05	0.000494	CcSEcCtD
Capecitabine—Visual impairment—Doxorubicin—muscle cancer	6.94e-05	0.000491	CcSEcCtD
Capecitabine—Vision blurred—Methotrexate—muscle cancer	6.82e-05	0.000483	CcSEcCtD
Capecitabine—Erythema multiforme—Doxorubicin—muscle cancer	6.81e-05	0.000482	CcSEcCtD
Capecitabine—Diarrhoea—Etoposide—muscle cancer	6.75e-05	0.000478	CcSEcCtD
Capecitabine—Eye disorder—Doxorubicin—muscle cancer	6.73e-05	0.000476	CcSEcCtD
Capecitabine—Ill-defined disorder—Methotrexate—muscle cancer	6.72e-05	0.000475	CcSEcCtD
Capecitabine—Tinnitus—Doxorubicin—muscle cancer	6.72e-05	0.000475	CcSEcCtD
Capecitabine—Anaemia—Methotrexate—muscle cancer	6.69e-05	0.000474	CcSEcCtD
Capecitabine—Cardiac disorder—Doxorubicin—muscle cancer	6.69e-05	0.000473	CcSEcCtD
Capecitabine—Flushing—Doxorubicin—muscle cancer	6.69e-05	0.000473	CcSEcCtD
Capecitabine—Angiopathy—Doxorubicin—muscle cancer	6.54e-05	0.000462	CcSEcCtD
Capecitabine—Malaise—Methotrexate—muscle cancer	6.53e-05	0.000462	CcSEcCtD
Capecitabine—Dizziness—Etoposide—muscle cancer	6.52e-05	0.000462	CcSEcCtD
Capecitabine—Immune system disorder—Doxorubicin—muscle cancer	6.51e-05	0.00046	CcSEcCtD
Capecitabine—Vertigo—Methotrexate—muscle cancer	6.51e-05	0.00046	CcSEcCtD
Capecitabine—Mediastinal disorder—Doxorubicin—muscle cancer	6.49e-05	0.000459	CcSEcCtD
Capecitabine—Leukopenia—Methotrexate—muscle cancer	6.48e-05	0.000459	CcSEcCtD
Capecitabine—Chills—Doxorubicin—muscle cancer	6.46e-05	0.000457	CcSEcCtD
Capecitabine—Arrhythmia—Doxorubicin—muscle cancer	6.44e-05	0.000455	CcSEcCtD
Capecitabine—Alopecia—Doxorubicin—muscle cancer	6.37e-05	0.00045	CcSEcCtD
Capecitabine—Cough—Methotrexate—muscle cancer	6.32e-05	0.000447	CcSEcCtD
Capecitabine—Mental disorder—Doxorubicin—muscle cancer	6.31e-05	0.000447	CcSEcCtD
Capecitabine—Vomiting—Etoposide—muscle cancer	6.27e-05	0.000444	CcSEcCtD
Capecitabine—Erythema—Doxorubicin—muscle cancer	6.27e-05	0.000444	CcSEcCtD
Capecitabine—Malnutrition—Doxorubicin—muscle cancer	6.27e-05	0.000444	CcSEcCtD
Capecitabine—Rash—Etoposide—muscle cancer	6.22e-05	0.00044	CcSEcCtD
Capecitabine—Dermatitis—Etoposide—muscle cancer	6.22e-05	0.00044	CcSEcCtD
Capecitabine—Headache—Etoposide—muscle cancer	6.18e-05	0.000437	CcSEcCtD
Capecitabine—Flatulence—Doxorubicin—muscle cancer	6.18e-05	0.000437	CcSEcCtD
Capecitabine—Chest pain—Methotrexate—muscle cancer	6.17e-05	0.000436	CcSEcCtD
Capecitabine—Myalgia—Methotrexate—muscle cancer	6.17e-05	0.000436	CcSEcCtD
Capecitabine—Arthralgia—Methotrexate—muscle cancer	6.17e-05	0.000436	CcSEcCtD
Capecitabine—Dysgeusia—Doxorubicin—muscle cancer	6.14e-05	0.000435	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	6.12e-05	0.000433	CcSEcCtD
Capecitabine—Discomfort—Methotrexate—muscle cancer	6.09e-05	0.000431	CcSEcCtD
Capecitabine—Back pain—Doxorubicin—muscle cancer	6.07e-05	0.000429	CcSEcCtD
Capecitabine—Muscle spasms—Doxorubicin—muscle cancer	6.03e-05	0.000427	CcSEcCtD
Capecitabine—Confusional state—Methotrexate—muscle cancer	5.96e-05	0.000422	CcSEcCtD
Capecitabine—Vision blurred—Doxorubicin—muscle cancer	5.91e-05	0.000418	CcSEcCtD
Capecitabine—Infection—Methotrexate—muscle cancer	5.87e-05	0.000415	CcSEcCtD
Capecitabine—Nausea—Etoposide—muscle cancer	5.86e-05	0.000415	CcSEcCtD
Capecitabine—Ill-defined disorder—Doxorubicin—muscle cancer	5.82e-05	0.000412	CcSEcCtD
Capecitabine—Nervous system disorder—Methotrexate—muscle cancer	5.8e-05	0.00041	CcSEcCtD
Capecitabine—Anaemia—Doxorubicin—muscle cancer	5.8e-05	0.00041	CcSEcCtD
Capecitabine—Thrombocytopenia—Methotrexate—muscle cancer	5.79e-05	0.000409	CcSEcCtD
Capecitabine—Skin disorder—Methotrexate—muscle cancer	5.74e-05	0.000406	CcSEcCtD
Capecitabine—Hyperhidrosis—Methotrexate—muscle cancer	5.71e-05	0.000404	CcSEcCtD
Capecitabine—Malaise—Doxorubicin—muscle cancer	5.65e-05	0.0004	CcSEcCtD
Capecitabine—Vertigo—Doxorubicin—muscle cancer	5.63e-05	0.000399	CcSEcCtD
Capecitabine—Anorexia—Methotrexate—muscle cancer	5.63e-05	0.000399	CcSEcCtD
Capecitabine—Syncope—Doxorubicin—muscle cancer	5.62e-05	0.000398	CcSEcCtD
Capecitabine—Leukopenia—Doxorubicin—muscle cancer	5.61e-05	0.000397	CcSEcCtD
Capecitabine—Palpitations—Doxorubicin—muscle cancer	5.54e-05	0.000392	CcSEcCtD
Capecitabine—Hypotension—Methotrexate—muscle cancer	5.52e-05	0.000391	CcSEcCtD
Capecitabine—Loss of consciousness—Doxorubicin—muscle cancer	5.51e-05	0.00039	CcSEcCtD
Capecitabine—Cough—Doxorubicin—muscle cancer	5.47e-05	0.000387	CcSEcCtD
Capecitabine—Hypertension—Doxorubicin—muscle cancer	5.41e-05	0.000383	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Methotrexate—muscle cancer	5.38e-05	0.000381	CcSEcCtD
Capecitabine—Insomnia—Methotrexate—muscle cancer	5.35e-05	0.000378	CcSEcCtD
Capecitabine—Myalgia—Doxorubicin—muscle cancer	5.34e-05	0.000378	CcSEcCtD
Capecitabine—Chest pain—Doxorubicin—muscle cancer	5.34e-05	0.000378	CcSEcCtD
Capecitabine—Arthralgia—Doxorubicin—muscle cancer	5.34e-05	0.000378	CcSEcCtD
Capecitabine—Anxiety—Doxorubicin—muscle cancer	5.32e-05	0.000376	CcSEcCtD
Capecitabine—Paraesthesia—Methotrexate—muscle cancer	5.31e-05	0.000376	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	5.3e-05	0.000375	CcSEcCtD
Capecitabine—Discomfort—Doxorubicin—muscle cancer	5.27e-05	0.000373	CcSEcCtD
Capecitabine—Dyspnoea—Methotrexate—muscle cancer	5.27e-05	0.000373	CcSEcCtD
Capecitabine—Dry mouth—Doxorubicin—muscle cancer	5.22e-05	0.000369	CcSEcCtD
Capecitabine—Dyspepsia—Methotrexate—muscle cancer	5.2e-05	0.000368	CcSEcCtD
Capecitabine—Confusional state—Doxorubicin—muscle cancer	5.16e-05	0.000365	CcSEcCtD
Capecitabine—Decreased appetite—Methotrexate—muscle cancer	5.14e-05	0.000364	CcSEcCtD
Capecitabine—Oedema—Doxorubicin—muscle cancer	5.12e-05	0.000362	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Methotrexate—muscle cancer	5.1e-05	0.000361	CcSEcCtD
Capecitabine—Fatigue—Methotrexate—muscle cancer	5.1e-05	0.000361	CcSEcCtD
Capecitabine—Infection—Doxorubicin—muscle cancer	5.08e-05	0.00036	CcSEcCtD
Capecitabine—Pain—Methotrexate—muscle cancer	5.05e-05	0.000358	CcSEcCtD
Capecitabine—Shock—Doxorubicin—muscle cancer	5.04e-05	0.000356	CcSEcCtD
Capecitabine—Nervous system disorder—Doxorubicin—muscle cancer	5.02e-05	0.000355	CcSEcCtD
Capecitabine—Thrombocytopenia—Doxorubicin—muscle cancer	5.01e-05	0.000355	CcSEcCtD
Capecitabine—Tachycardia—Doxorubicin—muscle cancer	4.99e-05	0.000353	CcSEcCtD
Capecitabine—Skin disorder—Doxorubicin—muscle cancer	4.97e-05	0.000352	CcSEcCtD
Capecitabine—Hyperhidrosis—Doxorubicin—muscle cancer	4.95e-05	0.00035	CcSEcCtD
Capecitabine—Anorexia—Doxorubicin—muscle cancer	4.88e-05	0.000345	CcSEcCtD
Capecitabine—Feeling abnormal—Methotrexate—muscle cancer	4.87e-05	0.000345	CcSEcCtD
Capecitabine—Gastrointestinal pain—Methotrexate—muscle cancer	4.83e-05	0.000342	CcSEcCtD
Capecitabine—Hypotension—Doxorubicin—muscle cancer	4.78e-05	0.000338	CcSEcCtD
Capecitabine—Urticaria—Methotrexate—muscle cancer	4.7e-05	0.000332	CcSEcCtD
Capecitabine—Body temperature increased—Methotrexate—muscle cancer	4.67e-05	0.000331	CcSEcCtD
Capecitabine—Abdominal pain—Methotrexate—muscle cancer	4.67e-05	0.000331	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	4.66e-05	0.00033	CcSEcCtD
Capecitabine—Insomnia—Doxorubicin—muscle cancer	4.63e-05	0.000328	CcSEcCtD
Capecitabine—Paraesthesia—Doxorubicin—muscle cancer	4.6e-05	0.000325	CcSEcCtD
Capecitabine—Dyspnoea—Doxorubicin—muscle cancer	4.56e-05	0.000323	CcSEcCtD
Capecitabine—Dyspepsia—Doxorubicin—muscle cancer	4.5e-05	0.000319	CcSEcCtD
Capecitabine—Decreased appetite—Doxorubicin—muscle cancer	4.45e-05	0.000315	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Doxorubicin—muscle cancer	4.42e-05	0.000313	CcSEcCtD
Capecitabine—Fatigue—Doxorubicin—muscle cancer	4.41e-05	0.000312	CcSEcCtD
Capecitabine—Pain—Doxorubicin—muscle cancer	4.38e-05	0.00031	CcSEcCtD
Capecitabine—Constipation—Doxorubicin—muscle cancer	4.38e-05	0.00031	CcSEcCtD
Capecitabine—Hypersensitivity—Methotrexate—muscle cancer	4.35e-05	0.000308	CcSEcCtD
Capecitabine—Asthenia—Methotrexate—muscle cancer	4.24e-05	0.0003	CcSEcCtD
Capecitabine—Feeling abnormal—Doxorubicin—muscle cancer	4.22e-05	0.000298	CcSEcCtD
Capecitabine—Gastrointestinal pain—Doxorubicin—muscle cancer	4.18e-05	0.000296	CcSEcCtD
Capecitabine—Pruritus—Methotrexate—muscle cancer	4.18e-05	0.000296	CcSEcCtD
Capecitabine—Urticaria—Doxorubicin—muscle cancer	4.07e-05	0.000288	CcSEcCtD
Capecitabine—Abdominal pain—Doxorubicin—muscle cancer	4.05e-05	0.000286	CcSEcCtD
Capecitabine—Body temperature increased—Doxorubicin—muscle cancer	4.05e-05	0.000286	CcSEcCtD
Capecitabine—Diarrhoea—Methotrexate—muscle cancer	4.04e-05	0.000286	CcSEcCtD
Capecitabine—Dizziness—Methotrexate—muscle cancer	3.91e-05	0.000277	CcSEcCtD
Capecitabine—Hypersensitivity—Doxorubicin—muscle cancer	3.77e-05	0.000267	CcSEcCtD
Capecitabine—Vomiting—Methotrexate—muscle cancer	3.76e-05	0.000266	CcSEcCtD
Capecitabine—Rash—Methotrexate—muscle cancer	3.73e-05	0.000264	CcSEcCtD
Capecitabine—Dermatitis—Methotrexate—muscle cancer	3.72e-05	0.000263	CcSEcCtD
Capecitabine—Headache—Methotrexate—muscle cancer	3.7e-05	0.000262	CcSEcCtD
Capecitabine—Asthenia—Doxorubicin—muscle cancer	3.67e-05	0.00026	CcSEcCtD
Capecitabine—Pruritus—Doxorubicin—muscle cancer	3.62e-05	0.000256	CcSEcCtD
Capecitabine—Nausea—Methotrexate—muscle cancer	3.51e-05	0.000248	CcSEcCtD
Capecitabine—Diarrhoea—Doxorubicin—muscle cancer	3.5e-05	0.000248	CcSEcCtD
Capecitabine—Dizziness—Doxorubicin—muscle cancer	3.38e-05	0.000239	CcSEcCtD
Capecitabine—Vomiting—Doxorubicin—muscle cancer	3.25e-05	0.00023	CcSEcCtD
Capecitabine—Rash—Doxorubicin—muscle cancer	3.23e-05	0.000228	CcSEcCtD
Capecitabine—Dermatitis—Doxorubicin—muscle cancer	3.22e-05	0.000228	CcSEcCtD
Capecitabine—Headache—Doxorubicin—muscle cancer	3.21e-05	0.000227	CcSEcCtD
Capecitabine—Nausea—Doxorubicin—muscle cancer	3.04e-05	0.000215	CcSEcCtD
